Lantern Pharma Competitors and Similar CompaniesClear all
Lantern Pharma's competitors and similar companies include centrose, NexImmune, Paige AI and BenevolentAI.
 centrose centrose is a biotechnology company engaged in the development and commercialization of antibody drug conjugates (ADCs), targeting disease-related cells. |  NexImmune NexImmune is a biopharmaceutical company developing immunotherapy products based on the Artificial Immune Modulation nanotechnology platform. |  Paige AI Paige is a company that develops artificial intelligence software for cancer diagnostics in pathology. |  BenevolentAI BenevolentAI is a company that develops artificial intelligence and machine learning technologies for drug discovery and life sciences. | ||
Founding Date | Founding Date 2013 | Founding Date 2007 | Founding Date 2011 | Founding Date 2017 | Founding Date 2013 |
Type | Type Public | Type Private | Type Public | Type Subsidiary | Type Private |
Tags | |||||
Locations | Locations Dallas, US HQ | Locations Middleton, US HQ | Locations Gaithersburg, US HQ | Locations New York, US HQ | Locations London, GB HQ Babraham, GB |
Employees | Employees 241100% increase | Employees N/A | Employees 5032% decrease | Employees 783% decrease | Employees 180 |
Valuation ($) | Valuation ($) 37.6 m | Valuation ($) N/A | Valuation ($) 372.4 k | Valuation ($) N/A | Valuation ($) 1 b |
Financial | |||||
Cost of goods | Cost of goods $7.4m (FY, 2025) | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A |
Net income | Net income ($17.1m) (FY, 2025) | Net income N/A | Net income ($32.3m) (FY, 2023) | Net income N/A | Net income (€63.3m) (FY, 2023) |
Funding | |||||
Latest funding round | Latest funding round N/A | Latest funding round $ 100k (over 12 years ago) | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 90m (over 6 years ago) |
Total funding raised | Total funding raised $ 4.7m | Total funding raised $ 100k | Total funding raised $ 33.8m | Total funding raised $ 220m | Total funding raised $ 305m |
For sources of this data, please see the company profile
View Company Profiles
centrose
HQ
Middleton, US
centrose is a biotechnology company engaged in the development and commercialization of antibody drug conjugates (ADCs), targeting disease-related cells.
View companyNexImmune
HQ
Gaithersburg, US
Employees
50↓ 32% decrease
NexImmune is a biopharmaceutical company developing immunotherapy products based on the Artificial Immune Modulation nanotechnology platform.
View companyPaige AI
HQ
New York, US
Paige is a company that develops artificial intelligence software for cancer diagnostics in pathology.
View companyBenevolentAI
HQ
London, GB
Employees
180
BenevolentAI is a company that develops artificial intelligence and machine learning technologies for drug discovery and life sciences.
View company